Healthcare Services Group Inc: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Oct 21, 2022 and accepted by EDGAR at Oct 21, 2022, 17:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-01 to 2022-09-30 | $414.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-01-01 to 2022-09-30 | $1.27bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-07-01 to 2022-09-30 | $376.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-01-01 to 2022-09-30 | $1.13bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2022-07-01 to 2022-09-30 | $35.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-01-01 to 2022-09-30 | $100.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $671.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | $6.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | $322.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | $18.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-07-01 to 2022-09-30 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-01-01 to 2022-09-30 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | $0.25 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-07-01 to 2022-09-30 | 74,348,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-01-01 to 2022-09-30 | 74,346,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | −$31.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-01-01 to 2022-09-30 | $4.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-01-01 to 2022-09-30 | $47.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2022-01-01 to 2022-09-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2022-09-30 | $512.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-30 | $722.2m | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $181.8m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2022-09-30 | $422.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000731012-22-000084. Last ingested by Listed: Oct 30, 2026, 13:40 ET. Listed shows no prices and gives no investment advice.